Latest News

Under the terms of the agreement, Chiesi will purchase KalVista for US$27 per share, representing a 36% premium over the company’s closing stock price on April 28.

The collaboration focuses on multiple research programmes designed to develop and commercialise site-specific recombinases for diseases characterised by severe unmet medical needs.

Using the new setup, clinicians can treat multiple oral conditions during one theatre session under general anaesthesia.

The liver centre combines several specialties, including hepatobiliary surgery, hepatology, gastroenterology, oncology, and interventional radiology.

Once fully implemented, Afya Apex is expected to improve efficiency, enhance transparency, strengthen accountability, and enable faster and more accurate patient care delivery.

The company expects the facility to increase production capacity and improve supply chain responsiveness across the Middle East and Africa (MEA).

The facility aims to improve access to primary and specialised healthcare services for residents within the rapidly growing residential community.

Globally, Heidi supports more than 2.5 million consultations each week as part of its broader mission to expand healthcare capacity.

The project received financial backing from First City Monument Bank (FCMB) and the Bank of Industry (BoI), reflecting a coordinated push to support local industry growth.

SMA is a rare inherited neuromuscular disorder that causes progressive muscle weakness and reduced mobility.